Product Certification&
Enterprise Certification
Country: China (Mainland)
Business Type:Lab/Research institutions
Tel: 86-15821988213
Mobile: 86-15821988213
Tel: 86-15821988213
Fax:
URL: http://www.longyupharma.com
Province/state: Shanghai
City: Shanghai
Street: Dalian Rd 950th
MaxCard:
CAS NO.107868-30-4
Exemestane in bulk supply global trade Hot Sale 107868-30-4
Exemestane is an irreversible steroid aromatase inhibitor. Its structure is similar to that of aromatase’s natural substrate, androstenedione, and acts as a pseudosubstrate. Postmenopausal women’s estrogen is mainly converted from androgen (produced by the adrenal cortex) by aromatase in the surrounding tissue. This drug irreversibly binds with the active site on aromatase to deactivate it, thus dramatically lower estrogen levels in the blood circulation of postmenopausal women. By inhibiting aromatase to lower estrogen levels, it can be used to treat hormone-dependent breast cancer in postmenopausal women.
Exemestane is suitable for treating advanced breast cancer in naturally or artificially postmenopausal women that has not responded well to tamoxifen treatment. It is also suitable for treating estrogen and progesterone receptor positive postmenopausal advanced breast cancer, and it can also be used to treat metastasized breast cancer and as adjuvant therapy for early breast cancer.
Exemestane is a steroidal irreversible CYP19 (aromatase) inhibitor. Exemestane is structurally related to natural androstenedione and acts as a false CYP19 enzyme substrate. This effect is also known as "suicide inhibition". Exemestane has been found to inhibit human placental CYP19
Exemestane is a third generation, irreversible steroidal aromatase inhibitor (Ki = 10.2 nM; Kinact = 26 nM) that induces aromatase degradation leading to a decrease in estrogen levels in plasma.As an androgen analog, exemestane exhibits androgenic effects and has been shown to decrease total and HDL cholesterol, apo A1, and total triglyceride levels.Marketed under the trade name Aromasin™, exemestane has been used to treat estrogen receptor-
Medchemexpress, HY-13632 10mg Exemestane CAS:107868-30-4 Exemestane (FCE 24304) is a selective, irreversible and orally active steroidal aromatase inhibitor with IC50s of 30 nM and 40 nM for human placental and rat ovarian aromatase, respectively. Exemestane can be used for hormone-dependent breast cancer research. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.